According to the announcement of the Zhixiang Jintai (688443.SH) on the Zhongtong Caijing APP, the company's product GR2001 injection has been included in the list of breakthrough therapeutic varieties by the Drug Evaluation Center of the National Medical Products Administration. It is reported that the GR2001 injection can specifically bind to the heavy chain C of tetanus neurotoxin, block its entry into neuronal cells, and prevent tetanus.